Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

iCardiac Technologies Inc.

www.icardiac.com

Latest From iCardiac Technologies Inc.

Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007

Highlights from the Q4 2007 review of medical device and in vitro diagnostics/research dealmaking: there was a boost in medical device acquisitions--with patient monitoring in particular, which accounted for about half the total of this period--capping off an impressive year in medtech M&A activity. Of note in the in vitro diagnostics/research space was glucose monitoring, which brought in 60% of the total GM segment's $160 million in financing for the entire year.
BioPharmaceutical Medical Device

Deals Update (01/2008)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device

iCardiac Technologies Inc.

Few issues are more nettlesome in drug development than the potential for a new drug to unleash rare but potentially lethal heart-rhythm irregularities. The industry has a glaring need for improved cardiac safety testing. iCardiac Technologies hopes to turn that need into a service business with its proprietary algorithms and advanced electrocardiogram biomarkers.
Regulation Research and Development Strategies

Start-Up Previews (03/07)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: Do-It-Yourself Dermatology, features profiles of Therative and Xthetix. Plus these Start-Ups Across Health Care: iCardiac Technologies, Jenken Biosciences, Neovasc Medical, and Syntaxin.
See All

Company Information

  • Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • Contract Research, Toxicology Testing-CRO
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Medical Devices
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • iCardiac Technologies Inc.
  • Senior Management
  • Mikael Totterman, CEO
    Jay Baker, CFO
    Alexandra Latypova, EVP, Sales & Mktg.
    Alex Zapesochny, Pres. & COO
  • Contact Info
  • iCardiac Technologies Inc.
    Phone: (585) 295-7610
    150 Allens Creek Rd.
    Rochester, NY 14618
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register